Urinary Incontinence (UI)NCT07637175
Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence
A study testing Chinese Herbal Medicine (CHM) supplement in people with Urinary Incontinence (UI), run by Kwantlen Polytechnic University at 1 site in Canada.
Trial summary
This study aims to evaluate the effectiveness and safety of Chinese herbal medicine in improving urinary incontinence symptoms among older adults. Urinary incontinence is a common condition in aging populations that can significantly impact quality of life, yet existing treatments are often limited by side effects or… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Urinary Incontinence (UI)
- What is being tested?
- Chinese Herbal Medicine (CHM) supplement
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 150 participants
- Where
- 1 siteCanada
- Study dates
- 1 Jun 2026to May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Experience symptoms of urinary incontinence (including stress, urge, or mixed incontinence) as confirmed by clinical assessment or validated screening tools.
- Able to understand the study procedures and provide informed consent.
- Willing and able to comply with study requirements, including attending study visits, and completing questionnaires.
- Stable general medical condition that, in the opinion of the investigator, does not interfere with participation in the study.
- Not currently participating in another interventional clinical trial that could affect urinary incontinence outcomes.
Who cannot join
- Inability to provide informed consent due to severe cognitive impairment or dementia.
- Known allergy or hypersensitivity to any component of the Chinese herbal medicine formulation.
- Presence of severe, unstable, or uncontrolled medical conditions that may pose a safety risk or interfere with participation, as determined by the investigator.
- Active urinary tract infection at the time of screening (eligible for reconsideration after treatment if appropriate).
- Current use of treatments for urinary incontinence that cannot be safely maintained at a stable dose throughout the study period.
- Significant neurological or urological conditions that severely affect bladder function, unless stable and deemed appropriate by the investigator.
- Participation in another interventional clinical trial that could influence study outcomes or participant safety.
- Any other condition that, in the opinion of the investigator, would compromise participant safety, study adherence, or data integrity.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site
Student Traditional Chinese Medicine Clinic
Richmond, British Columbia, V6X 3X7
About this study
Official title: Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence: A Randomized Double-Blind Placebo-Controlled Clinical Trial
This study aims to evaluate the effectiveness and safety of Chinese herbal medicine in improving urinary incontinence symptoms among older adults. Urinary incontinence is a common condition in aging populations that can significantly impact quality of life, yet existing treatments are often limited by side effects or insufficient efficacy.
The primary research question is whether a standardized Chinese herbal formula can reduce the frequency and severity of urinary incontinence compared to a placebo. We hypothesize that participants receiving the herbal intervention will demonstrate greater improvement in urinary symptoms and quality of life measures than those receiving placebo, without significant adverse effects.
Read more
To test this hypothesis, a randomized, double-blind, placebo-controlled clinical trial will be conducted. Eligible older adults will be randomly assigned to receive either the herbal treatment or a matched placebo over a defined study period. Outcomes will include validated measures of urinary incontinence severity, frequency of episodes, and patient-reported quality of life.
Potential benefits of this research include generating high-quality evidence on the effectiveness and safety of Chinese herbal medicine for urinary incontinence, which may inform clinical practice and expand treatment options for older adults. If effective, this intervention could offer a complementary or alternative approach with fewer side effects, contributing to improved symptom management and overall well-being in this population.
- Conditions
- Urinary Incontinence (UI)
- Being tested
- Chinese Herbal Medicine (CHM) supplement, Placebo Control
- Keywords
- Traditional Chinese Medicine, Urinary Incontinence, Herbal Treatment, Stage IV Clinical Trial, Older Adults
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Chinese Herbal Medicine (CHM) supplementOther
Chinese Herbal Medicine (CHM) supplement
Placebo ControlOther
Placebo Control
| Study group | Role | What they receive |
|---|---|---|
| Chinese Herbal Intervention | Experimental | Standardized Chinese herbal medicine Receives: Other: Chinese Herbal Medicine (CHM) supplement |
| Control Group | Placebo comparator | Placebo Receives: Other: Placebo Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF).
Primary outcomes will focus on the frequency and severity of urinary incontinence episodes, measured using validated questionnaires. Min = 0 and Max = 6, with higher scores indicating more frequent/severe urinary incontinence.
Measured: From enrollment to approximately week 4.
Secondary outcomes (1)
Urinary Incontinence Quality of Life Questionnaire (I-QOL)
Secondary outcomes include quality of life, symptom distress, and any adverse events. A mean score for each subscale is calculated (averaging the scores for the items in each subscale) as well as a total score for all 22 items (sum of all subscale scores). The scores are then transformed to a 'Scale score' ranging from 0-100 points for ease of interpretation: Scale score = (sum of the items - lowest possible score)/possible raw score range X 100.
Measured: From enrollment to approximately Week 4.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jun 2026
- Study start1 Jun 2026 (estimated)
- Primary completionDec 2027 (estimated)
- Study completionMay 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary Incontinence (UI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kwantlen Polytechnic University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, John Yang, Kwantlen Polytechnic University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07637175
- Sponsor's protocol ID
- KPU REB # 2022-22
- Status last verified
- Jun 2026
- First submitted
- 2 Jun 2026
- Last updated
- 9 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IDP) will not be shared to adhere to the requirements of our Research Ethics Board Approval.
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT07637175
- Acronym / sponsor ID
- KPU REB # 2022-22
- Conditions
- Urinary Incontinence (UI)
- Keywords
- Traditional Chinese Medicine, Urinary Incontinence, Herbal Treatment, Stage IV Clinical Trial, Older Adults
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Kwantlen Polytechnic UniversityUniversity, hospital or other
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- May 2028 (estimated)
- First posted
- 9 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effectiveness and safety of Chinese herbal medicine in improving urinary incontinence symptoms among older adults. Urinary incontinence is a common condition in aging populations that can significantly impact quality of life, yet existing treatments are often limited by side effects or insufficient efficacy.
The primary research question is whether a standardized Chinese herbal formula can reduce the frequency and severity of urinary incontinence compared to a placebo. We hypothesize that participants receiving the herbal intervention will demonstrate greater improvement in urinary symptoms and quality of life measures than those receiving placebo, without significant adverse effects.
To test this hypothesis, a randomized, double-blind, placebo-controlled clinical trial will be conducted. Eligible older adults will be randomly assigned to receive either the herbal treatment or a matched placebo over a defined study period. Outcomes will include validated measures of urinary incontinence severity, frequency of episodes, and patient-reported quality of life.
Potential benefits of this research include generating high-quality evidence on the effectiveness and safety of Chinese herbal medicine for urinary incontinence, which may inform clinical practice and expand treatment options for older adults. If effective, this intervention could offer a complementary or alternative approach with fewer side effects, contributing to improved symptom management and overall well-being in this population.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Chinese Herbal Intervention | Experimental | Other: Chinese Herbal Medicine (CHM) supplementStandardized Chinese herbal medicine |
| Control Group | Placebo comparator | Other: Placebo ControlPlacebo |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Experience symptoms of urinary incontinence (including stress, urge, or mixed incontinence) as confirmed by clinical assessment or validated screening tools.
- Able to understand the study procedures and provide informed consent.
- Willing and able to comply with study requirements, including attending study visits, and completing questionnaires.
- Stable general medical condition that, in the opinion of the investigator, does not interfere with participation in the study.
- Not currently participating in another interventional clinical trial that could affect urinary incontinence outcomes.
Key exclusion criteria (8 listed)
- Inability to provide informed consent due to severe cognitive impairment or dementia.
- Known allergy or hypersensitivity to any component of the Chinese herbal medicine formulation.
- Presence of severe, unstable, or uncontrolled medical conditions that may pose a safety risk or interfere with participation, as determined by the investigator.
- Active urinary tract infection at the time of screening (eligible for reconsideration after treatment if appropriate).
- Current use of treatments for urinary incontinence that cannot be safely maintained at a stable dose throughout the study period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Chinese Herbal Medicine (CHM) supplementChinese Herbal Medicine (CHM) supplement | Other | Chinese Herbal Intervention |
| Placebo ControlPlacebo Control | Other | Control Group |
Primary outcome
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF).
Time frame: From enrollment to approximately week 4.
Primary outcomes will focus on the frequency and severity of urinary incontinence episodes, measured using validated questionnaires. Min = 0 and Max = 6, with higher scores indicating more frequent/severe urinary incontinence.
1 secondary outcome
Urinary Incontinence Quality of Life Questionnaire (I-QOL)
Time frame: From enrollment to approximately Week 4.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2026.
- Individual participant dataSharing planned: No. Individual participant data (IDP) will not be shared to adhere to the requirements of our Research Ethics Board Approval.
Related trials for Urinary Incontinence (UI)
Active, not recruitingObservational study
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Not yet recruitingObservational study
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
Urinary Incontinence (UI)
Recruiting
Ambulatory Long Length URodynamics Evaluation
Urology, Urinary Bladder, Overactive
Recruiting
Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.
Urinary Incontinence, Mixed Urinary Incontinence
Not yet recruiting
Transcutaneous Tibial Nerve Stimulation for Urinary Incontinence After Radical Prostatectomy
Urinary Incontinence (UI), Prostatectomy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Chinese Herbal Medicine (CHM) supplement in people with Urinary Incontinence (UI), run by Kwantlen Polytechnic University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact John Yang, Dr. (604-599-2286, john.yang@kpu.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). (time frame: From enrollment to approximately week 4.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.